TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PETMartha W. den Hollander, Annemiek Walenkamp|Journal of Nuclear Medicine|2015Cited by 99
Defining EGFR amplification status for clinical trial inclusionPim J. French, Martin J. van den Bent, Marica Eoli et al.|Neuro-Oncology|2019Cited by 44
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumourHelle‐Brit Fiebrich, Elisabeth G.E. de Vries, Johan R. de Jong et al.|European Journal of Nuclear Medicine and Molecular Imaging|2011Cited by 42
Neuroendocrine tumours and their microenvironmentLotte D. de Hosson, Annemiek Walenkamp|Cancer Immunology Immunotherapy|2020Cited by 26
Myocardial Metastases on 6-[18F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour PatientsWalter Noordzij, Rudi Dierckx, André P. van Beek et al.|PLoS ONE|2014Cited by 24